Home › Endometriumkanker › New Mexico › Albuquerque
Endometriumkanker klinische studies in Albuquerque, NM
12 studies voor Endometriumkanker zoeken deelnemers op locaties in en rond Albuquerque (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
RekruterenFase 3
- University of New Mexico Cancer Center, Albuquerque
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
RekruterenFase 2
- University of New Mexico Cancer Center, Albuquerque
Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
RekruterenFase 1
- University of New Mexico Cancer Center, Albuquerque
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
RekruterenFase 2
- University of New Mexico Cancer Center, Albuquerque
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
RekruterenFase 2
- Research Site, Albuquerque
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
RekruterenFase 3
- University of New Mexico Comprehensive Cancer Center ( Site 6046), Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Albuquerque
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
RekruterenFase 3
- Research Site, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruterenFase 2
- 292, Albuquerque
Uterine Preservation Via Lifestyle Transformation
RekruterenFase 2
- University of New Mexico, Albuquerque
Zanzalintinib in Combination With Paclitaxel in Recurrent High Grade Uterine Cancer
RekruterenFase 1
- University of New Mexico, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Albuquerque
Endometriumkanker studies in andere steden
- Houston, TX68 studies
- New York City, NY52 studies
- Boston, MA50 studies
- Arlington, VA39 studies
- Nashville, TN38 studies
- Los Angeles, CA34 studies
- St. Louis, MO29 studies
- Philadelphia, PA28 studies
- San Antonio, TX27 studies
- Columbus, OH25 studies
- Oklahoma City, OK25 studies
- Chicago, IL25 studies
Andere studies in Albuquerque
- Niet-kleincellige longkanker18 studies
- Borstkanker17 studies
- Eierstokkanker15 studies
- Kanker (alle vormen)14 studies
- Longkanker14 studies
- Metastatische kanker12 studies
- Type 2-diabetes11 studies
- Cardiovasculaire ziekte10 studies
- Melanoom9 studies
- Acute myeloïde leukemie9 studies
- Prostaatkanker9 studies
- Chronische nierziekte8 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.